<qa>  What is the name of the type of infection that would interfere with study participation or safety?13. Concurrent disease or condition that would interfere with study participation or safety, such as any of the following: Active, clinically significant infection either grade 2 by National Cancer Institute NCI Common Terminology Criteria for Adverse Events CTCAE v4.03 or requiring the use of parenteral anti-microbial agents within 14 days before Day 1 of study drug Clinically significant bleeding diathesis or coagulopathy, including known platelet function disorders Non-healing wound, ulcer, or bone fracture 